CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
Potlako: A Programmatic Intervention to Improve Access to Timely Oncology Care
- Status
- COMPLETED
- Phase
- NA
Evaluation Of Lymph Nodes After Neoadjuvant Chemotherapy
- Status
- WITHDRAWN
- Phase
- NA
Hereditary Risk Factors for Thyroid Cancer
- Status
- RECRUITING
- Phase
- NA
Meaning-Centered Psychotherapy Training for Cancer Care Providers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Investigation of the Genetics of Hematologic Diseases
- Status
- RECRUITING
- Phase
- N/A
Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström Macroglobulinemia
- Status
- COMPLETED
- Phase
- PHASE2
Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
- Status
- RECRUITING
- Phase
- PHASE2
Matched Targeted Therapy For High-Risk Leukemias and Myelodysplastic Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Early Patient Access Single Named Patient Program for the Use of Ulocuplumab for the Treatment of Multiple Myeloma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Prospective Registry of Multiplex Testing (PROMPT)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer
- Status
- TERMINATED
- Phase
- PHASE1
GO-203-2C + Bortezomib For Relapsed Or Refractory MM
- Status
- WITHDRAWN
- Phase
- PHASE1
Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA